Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Peptides  >  CEF Control Peptides  >>  CEF Control Peptide Pool

Product Name CEF Control Peptide Pool
Size 1 mg
Catalog # AS-61036-003
US$ $115
Description

This product contains 0.03 mg (net) of the 32 CEF peptides for a total of 1 mg in one vial. Used in the stimulation of IFNγ release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays.

Detailed Information Flyer
Storage -20C
References Ref: NIH AIDS Research and Reference Reagent Program; Currier, JR. et al. J. Immunol. Methods 260, 157 (2002); Mwau, M. et al. AIDS REs. Hum. Retroviruses 18, 611 (2002).
Product Citations Chiu, YL. et al. (2014). Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest 124, 198. doi: 10.1172/JC170510.
Wick, DA. et al. (2014). Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res 20, 1125.
Cecil, DL. et al. (2013). T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity. Breast Cancer Res Treatment 139, 657.
Dhodapkar, KM. et al. (2013). SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer. Oncoimmunol 2, e25205. doi: 10.4161/onci.25205.
Eypper, EH. et al. (2013). Transcutaneous immunization of healthy volunteers with an attenuated Listeria monocytogenes vaccine strain and cholera toxin adjuvant. Vaccine 31, 3257.
Sedegah, M. et al. (2013). Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP). Malaria J 12, 185.
Bayard, F. et al. (2012). T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO. J Viral Hepatitis 19, 872. doi: 10.1111/j.1365-2893.2012.01611.x.
Fairman, P. & JB. Angel (2012). The effect of human immunodeficiency virus-1 on monocyte-derived dendritic cell maturation and function. Clin Exp Immunol 170, 101. doi: 10.1111/j.1365-2249.2012.04628.x.
Habersetzer, F. et al. (2011). A Poxvirus vaccine is safe, induces T-Cell responses, and decreases viral load in patients with chronic Hepatitis C. Gastroenterol 141, 890. http://www.sciencedirect.com/science/article/pii/S0016508511007669
Matijevic, M. et al. (2011). Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11. Cellular Immunol 270, 62.
Olson, WC. et al. (2011). Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and
Richmond, M. et al. (2011). Epitope mapping of HIV-specific CD8+ T cell responses by multiple immunological readouts reveals distinct specificities defined by function. J Virol 85, 1275. doi: 10.1128/JVI.01707-10.
Nielsen, JS. et al. (2010). An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. J Immunol Methods 360, 149.
Boaz, M. et al. (2008). Measuring T-cell immunity in HIV vaccine clinical trials: PBMC and ELISPOT assay proficiency concordance in laboratories from 3 continents. Clin Vaccine Immunol doi:10.1128/CVI.00326-08.
Jones, RB. et al. (2008). Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205, 2763. doi: 10.1084/jem.20081398.
Bull, M. et al. (2007). Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 322, 57.
Moodie, Z. et al. (2006). Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. J Immunol Methods 315, 121.
     
  < Back